Skip to main content
. 2019 Nov 22;7(11):e14946. doi: 10.2196/14946

Table 1.

Participant characteristics.

Characteristics Completing study (n=94)
Age (years), mean (SD) 69.7 (9.3)
Male, n (%) 57 (60.6)
BMIa, n (%)

Underweight 3 (5.9)

Normal weight 14 (27.5)

Overweight 16 (31.4)

Obese 18 (35.3)
FEV1%b, mean (SD) 47.7 (15.9)
GOLDc staging, n (%)

Moderate 37 (39.4)

Severe 40 (42.6)

Very severe 17 (18)
Smoking status, n (%)

Current smoker 18 (19.2)

Exsmoker (<2 years) 13 (13.8)

Exsmoker (≥2 years) 63 (67)
Years smoking, median (IQR) 40 (29-55)
MRCd dyspnea score, n (%)

2 15 (16)

3 64 (68.1)

4 15 (16)
EQ-5De index, median (IQR) 0.6 (0.5-0.7)
SCL10f, median (IQR) 3 (1-9)
SCL20af, median (IQR) 10.5 (7-23)
SGRQ-Cg, mean (SD) 56.5 (18.8)
BMQh, mean (SD) 32.6 (6.2)
MARSi, median (IQR) 24 (23-25)

aBMI: body mass index.

bFEV1%: Forced Expiratory Volume in 1 second.

cGOLD: Global Initiative for Chronic Obstructive Pulmonary Disease.

dMRC: Medical Research Council.

eEQ-5D: EuroQol 5-Dimension Questionnaire.

fSCL: Symptom Checklist.

gSGRQ-C: St George’s Respiratory Questionnaire for Chronic Obstructive Lung Disease.

hBMQ: Beliefs about Medications Questionnaire.

iMARS: Medication Adherence Report Schedule.